Archive for the ‘Media Control’ Category

Taking Control of Your AWS Bill – The Media Temple Blog

We learn from the RightScale (now Flexera) 2019 State of the Cloud Report that cloud adoption has become pretty much universal, and public cloud adoption is growing significantly. Some of the key report takeaways are:

The same report also highlights that the top cloud challenge for the third year in a row is managing cloud spend, while optimizing cloud costs is the #1 priority of central IT. The respondents themselves estimate that 27% of their cloud spend is wasted, while Flexera has measured actual waste among their customers at 35%. But managing cloud budgets effectively requires near real-time visibility into actual costsoften across multiple accounts, numerous projects, and a multitude of self-provisioning users.

This is a two-part blog post series. In this first post, we explore the Amazon Web Services (AWS) suite of cost. Later next week, well explore the usage of management tools that can help you take control of your AWS bill.

As of early 2018, the AWS Cost and Usage report has become the default AWS tool for tracking and billing cloud usage. Downloaded from the Amazon Simple Storage Service (Amazon S3) console, this CSV report contains a line item for each usage of an AWS resource or service. Three times a day, a cumulative update is delivered to a user-specified Amazon S3 bucket. At the end of the month, the report is finalized into an invoice.

The AWS Cost and Usage report is free of charge (up to five reports per AWS account). With line items aggregated on either an hourly or daily basis (as specified by the account owner), a report can contain literally millions of lines. In this section, we review how the report is structured and the key cost elements that it tracks.

A number of fields in the report are dedicated to precisely identifying the AWS product for which the charge has been incurred. These fields include the instance type (such as Amazon EC2), the instance type family (such as t2 or m4), the operating system, the product family (such as compute or storage), and the geographic AWS Region in which the usage took place. In addition, a unique SKU is generated for each product by combining three line item details (see Line Items: Defining Billing and Usage Parameters below): ProductCode, UsageType, and Operation.

The line item fields provide detailed information on the type of operation, its relevant costs, and various high-level billing parameters, such as the legal billing entity, the billing currency, the taxes to be applied, and the type of charge (which could also be a refund or a credit).

For example, the three line item fields that are used to generate the product SKU (see Identifying the Product above) are:

For on-demand resources (versus Reserved Instances, see Tracking Reserved Instances below), usage duration metrics are provided by three fields:

The cost of on-demand usage for a single account is shown in the UnblendedCost field, which is calculated by multiplying the UnblendedRate (the current AWS pricing rate for the resource or service) by the UsageAmount. See Consolidated Billing below for an explanation of blended costs across multiple accounts when using the AWS Organizations service.

Reserved Instances (RIs) are pre-provisioned instance-hours for AWS resources such as Amazon EC2 or Amazon Relational Database Service (Amazon RDS) instances. In general, the usage costs for pre-provisioned resources are significantly lower than for on-demand resources. The depth of the RI discount is determined by the term (one or three years) and the payment model (All Upfront, Partial Upfront, or No Upfront). If the RIs are all in the same Availability Zone, they are also a capacity reservation. In addition, Linux or Unix Amazon EC2 RIs in the same Region (and configured for shared tenancy) are size-flexible. In other words, the RI discount, which is normally applicable only to the specified instance size, can be applied on the fly to any instance size in the instance family.

It can be very tricky to track the actual cost of an RI in any given billing period. The AWS Cost and Usage report uses the following fields to give as clear a picture as possible of RI costs:

In addition to the effective RI costs incurred, the AWS Cost and Usage report also shows RI capacity that has not been used yet during the month or, in the case of the final invoice, was not used during the monthly billing period.

An organization can consolidate billing across all its AWS accounts into a single invoice and thus better leverage volume pricing tiers and RI discounts. The master account pays for all the charges aggregated by the linked member accounts, but each member account also gets its own bill for showback or chargeback purposes.

When billing is consolidated, the AWS Cost and Usage report uses blended rates (i.e., the averaged rates of the RIs and the on-demand instances used by all the member accounts). In the Line Item details, this will be shown in the following two fields:

Stay tuned next week for the second part of this series where we explore the usage of management tools that can help you take control of your AWS bill.

As an AWS Advanced Consulting Partner, Media Temple can help you get the most from your AWS cloud.Reach out anytime.

More here:
Taking Control of Your AWS Bill - The Media Temple Blog

Kindred Biosciences Receives FDA Approval of Zimeta (dipyrone injection) for the Control of Pyrexia in Horses – TheHorse.com

San Francisco, California (November 25, 2019) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that the U.S. Food and Drug Administrations Center for Veterinary Medicine has approved Zimeta (dipyrone injection) for the control of pyrexia in horses.

Pyrexia, or fever, is associated with a number of underlying diseases and can result in significant negative outcomes, including dehydration, laminitis, muscle wasting, weight loss, and in some cases death. Among performance horses, fever can also lead to loss of training and competition days. There are more than eight million horses in the United States, and over one million are seen by a veterinarian for fever annually.

Zimeta is the first and only FDA-approved medication for the control of pyrexia (fever) in horses.

The equine community has been eagerly anticipating an FDA-approved safe and effective product to control fever in horses, said Denise Bevers, President and COO of KindredBio. Equine pyrexia is an attractive market for KindredBio, with high unmet medical need and a commitment to treat. This second KindredBio commercial product was developed in five years and at a cost of $5 million, consistent with our business model. It positions KindredBio as a key player in the equine community as we advance a pipeline of promising drug candidates for horses.

Zimeta, which is classified as a nonsteroidal anti-inflammatory drug, targets fever centrally in the brain, where it originates. In a clinical study, Zimeta demonstrated rapid and effective fever reduction in horses with naturally occurring fever. The most common cause of fever in horses is respiratory disease, both viral and bacterial, but fever also can occur with other infections or inflammation of any body system. Zimeta is administered intravenously at 30 mg/kg once or twice daily, at 12-hour intervals, for up to three days. The overall number of doses and duration of treatment is dependent on the response observed (fever reduction). Zimeta may be re-administered based on recurrence of fever for up to three days.

KindredBio is proud to be a member of the American Association of Equine Practitioners (AAEP) Educational and Media Partners Program. The program represents industry-leading corporations, media outlets, and industry organizations dedicated to providing resources and education through AAEP to equine veterinarians and horse owners to improve the health and welfare of the horse. Nearly 9,300 veterinarians and veterinary students across more than 60 countries are members of the AAEP.

###

Important Safety Information

ZimetaTM(dipyrone injection) should not be used more frequently than every 12 hours. For use in horses only.Do not use in horses with a hypersensitivity to dipyrone, horses intended for human consumption or any food producing animals, including lactating dairy animals. Not for use in humans, avoid contact with skin and keep out of reach of children.Take care to avoid accidental self-injection and use routine precautions when handling and using loaded syringes. Prior to use, horses should undergo a thorough history and physical examination by a veterinarian.Monitor for signs of abnormal bleeding and use caution in horses at risk for hemorrhage.Concurrent use with other NSAIDs, corticosteroids and drugs associated with kidney toxicity, should be avoided.As a class, NSAIDs may be associated with gastrointestinal, kidney, and liver toxicity. The most common adverse reactions observed during clinical trials were elevated glucose conversion enzymes, decreased blood protein, and gastric ulcers. Please see the fullPrescribing Information.

Mirataz(mirtazapine transdermal ointment) is for topical use in cats only under veterinary supervision. Do not use in cats with a known hypersensitivity to mirtazapine or any of the excipients or in cats treated with monoamine oxidase inhibitors (MAOIs). Not for human use. Keep out of reach of children. Wear gloves to apply and wash hands after. Avoid contact with treated cat for 2 hours following application. The most common adverse reactions include application site reactions, behavioral abnormalities (vocalization and hyperactivity) and vomiting. Please see the fullPrescribing Information.

About Kindred Biosciences

Kindred Biosciences is a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The companys strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. KindredBio has a deep pipeline of novel drugs and biologics in development across many therapeutic classes. The company has two approved drugs, namelyMirataz(mirtazapine transdermal ointment) for the management of weight loss in cats andZimeta(dipyrone injection) for the control of fever in horses.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding our expectations about the trials, regulatory approval, manufacturing, distribution and commercialization of our current and future product candidates, and statements regarding our anticipated revenues, expenses, margins, profits and use of cash.

These forward-looking statements are based on our current expectations. These statements are not promises or guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results to be materially different from any future results expressed or implied by the forward-looking statements. These risks include, but are not limited to, the following: our limited operating history and expectations of losses for the foreseeable future; the absence of significant revenue from our products and our product candidates for the foreseeable future; the likelihood that our revenue will vary from quarter to quarter; our potential inability to obtain any necessary additional financing; our substantial dependence on the success of our products and our lead product candidates which may not be successfully commercialized even if they are approved for marketing; the effect of competition; our potential inability to obtain regulatory approval for our existing or future product candidates; our dependence on third parties to conduct some of our development activities; our dependence upon third-party manufacturers for supplies of our products and our product candidates; uncertainties regarding the outcomes of trials regarding our product candidates; our potential failure to attract and retain senior management and key scientific personnel; uncertainty about our ability to develop a satisfactory sales organization; our significant costs of operating as a public company; our potential inability to obtain and maintain patent protection and other intellectual property protection for our products and our product candidates; potential claims by third parties alleging our infringement of their patents and other intellectual property rights; our potential failure to comply with regulatory requirements, which are subject to change on an ongoing basis; the potential volatility of our stock price; and the significant control over our business by our principal stockholders and management.

For a further description of these risks and other risks that we face, please see the risk factors described in our filings with theU.S. Securities and Exchange Commission(theSEC), including the risk factors discussed under the caption Risk Factors in our Annual Report on Form 10-K and any subsequent updates that may be contained in our Quarterly Reports on Form 10-Q filed with theSEC. As a result of the risks described above and in our filings with theSEC, actual results may differ materially from those indicated by the forward-looking statements made in this press release. Forward-looking statements contained in this press release speak only as of the date of this press release and we undertake no obligation to update or revise these statements, except as may be required by law.

Follow this link:
Kindred Biosciences Receives FDA Approval of Zimeta (dipyrone injection) for the Control of Pyrexia in Horses - TheHorse.com

OOIDA issues Call to Action against worker classification bills – Land Line – Land Line Media

The Owner-Operator Independent Drivers Association is asking its more than 160,000 members to speak out against two New Jersey bills that could negatively affect independent small-business truckers.

On Monday, Nov. 25, OOIDA issued a Call to Action to its members, requesting that they write or call the lawmakers who are pushing for the legislation in New Jersey.

The bills, S4204 and A5936, would enact the ABC test, which considers all workers to be employees unless the hiring business demonstrates that all of these factors are established:

A. That the worker is free from the control and direction of the hirer in connection with the performance of the work, both under the contract for the performance of the work and in fact.

B. That the worker performs work that is outside the usual course of the hiring entitys business.

C. That the worker is customarily engaged in an independently established trade, occupation, or business of the same nature as that involved in the work performed.

This past September, California Gov. Gavin Newsom signed into law AB5, which codifies the California Supreme Courts decision to establish the ABC test. The law, which is set to go into effect Jan. 1, is not exclusive to the trucking industry.

Opponents in the trucking industry have said that the B factor of the test could spell the end of the leased owner-operator model in the state. Some owner-operators in California have already reported to OOIDA that their motor carriers have said they will either need to sell their trucks and become an employee or relocate to another state.

After being unable to receive clear answers from officials in either state about how the legislation would affect owner-operators, OOIDA spoke out last week against the efforts in California and New Jersey.

We have attempted to get answers, any answers from officials in California regarding their vision and enforcement on AB5. No one has any, OOIDA President and CEO Todd Spencer said. Absent any sort of direction or credible information, California should not allow AB5 to go into effect in January.

With Californias law headed to court, OOIDA said New Jersey should not pass similar legislation.

Its apparent with the confusion in California that no state needs to move forward on overly broad legislation targeting independent contractors until lawmakers can articulate what any changes to current law would be, Spencer said.

OOIDA also sent a letter to New Jersey lawmakers to state its concerns.

Costly and lengthy litigation is likely a foregone conclusion absent significant changes in the states laws and regulations that deal with independent truckers, OOIDA wrote.

OOIDA wants its members to contact the New Jersey lawmakers as well.

New Jersey State Sen. Stephen Sweeney, State Assemblyman Wayne DeAngelo and State Assemblyman Joseph Egan are leading this misguided legislative effort, OOIDA wrote in its Call to Action. Were asking all of our members not just those who reside in New Jersey to call or email each of their offices and let them know how you feel about this.

Contact information for the lawmakers is included in the Call to Action.

Read more from the original source:
OOIDA issues Call to Action against worker classification bills - Land Line - Land Line Media

Doctors are turning to YouTube to learn how to do surgical procedures, but there’s no quality control – CNBC

Dr. Kalkidan Biahu, Dr. Mike Kim, and Dr. John Carroll perform a minimally invasive surgery at one of the University of Colorado Hospital's catheter labs on Thursday, July 17, 2014 in Aurora, CO.

Kent Nishimura | Denver Post | Getty Images

When Dr. Justin Barad was a medical resident, he would often encounter a problem he'd never managed or be asked to use a device without much training.

So he'd turn to YouTube.

Barad, who completed his surgical training at UCLA in 2015, said YouTube has become a fixture of medical education. He'd often get prepped by watching a video before a procedure. Sometimes he'd even open a YouTube video in the operating theater when confronted with a particularly challenging surgery or unexpected complication.

"I don't know a surgeon who hasn't had a similar experience," said Barad, who has now started a surgical training company called Osso VR.

CNBC found tens of thousands of videos showing a wide variety of medical procedures on the Google-owned video platform, some of them hovering around a million views. People have livestreamed giving birth and broadcast their face-lifts. One video, which shows the removal of a dense, white cataract, has gone somewhat viral and now has more than 1.7 million views. Others seem to have found crossover appeal with nonmedical viewers, such as a video from the U.K.-based group Audiology Associates showing a weirdly satisfying removal of a giant glob of earwax.

Doctors are uploading these videos to market themselves or to help others in the field, and the amount is growing by leaps and bounds. Researchers in January found more than 20,000 videos related to prostate surgery alone, compared with just 500 videos in 2009.

The videos are a particular boon for doctors in training. When the University of Iowa surveyed its surgeons, including its fourth-year medical students and residents, itfound that YouTubewas the most-used video source for surgical preparation by far.

But residents and medical students are not the only ones tuning in. Experienced doctors, like Stanford Hospital's vascular surgeon Dr. Oliver Aalami said he turned to YouTube recently ahead of a particularly difficult exposure.

"It was helpful, but I kept thinking that some of these videos should be verified," he said, "A bit like Twitter and its blue badges."

There's one problem with this practice that will be familiar to anybody who's searched YouTube for tips on more mundane tasks like household repairs. How can doctors tell which videos are valid and which contain bogus information?

For instance, one recent study found more than 68,000 videos associated with a common procedure known as a distal radius fracture immobilization. The researchers evaluated the content for their technical skill demonstrated and educational skill, and created a score. Only 16 of the videos even met basic criteria, including whether they were performed by a health-care professional or institution. Among those, the scores were mixed. In several cases, the credentials of the person performing the procedure could not be identified at all.

Even more concerning, studies are finding that the YouTube algorithm is highly ranking videos where the technique isn't optimal. A group of researchers found that for a surgical technique called a laparoscopic cholecystectomy, about half the videos showed unsafe maneuvers.

Medical experts say this content hasn't been particularly well curated, in part because it's an expensive process. Massive-scale internet platforms like YouTube limit expenses by stressing that they are a platform with some basic rules, and they don't vet or add editorial notes to content. YouTube doesn't claim to be accredited for medical education, and therefore can surface content based on popularity and not on quality.

YouTube did not return a request for comment about its surgical content. Google Health declined to comment.

One solution would be paying a group of doctors to do the work of vetting surgical videos, suggests Dr. Joshua Landy, a Canadian physician who developed an Instagram-like service for doctors called Figure 1. "You'd need to be experienced to distinguish between the surgeries done properly and the technique is the most up-to-date and safe," he said.

For patients watching the surgeries to get a sense for what happens once they go under, that kind of heavy-handed curation might not be necessary. But it's a pressing need for inexperienced physicians, who rely on the videos to fill gaps in their medical education before they perform the procedures.

"Seeing cases is what makes you better at medicine because there's always unusual things you'll have to navigate," said Landy. "So many doctors will watch these videos over and over again for thousands of hours."

Google seems to be aware of the problem. But so far, the company has only made some small steps to provide some rules around graphic medical videos. Those uploading the videos must share descriptive titles, so users know what they're in for, and the purpose must be to educate rather than to offend or surprise a viewer. One thing that's not allowed, for instance, is footage from a procedure featuring open wounds where there's no clear explanation to viewers.

But the company might deviate from its hands-off policy to do more in the coming months. Google's vice president of health, David Feinberg, noted at a recent medical conference in the fall that a lot of surgeons are flocking to YouTube. He implied, without sharing specifics, that his team would look to do a better job of managing the content as part of its broader focus on combating health misinformation across Google.

Medical experts say they're more than willing to work with YouTube to help curate medical content.

Many academic medical centers, notes Jefferson Health's chief executive Dr. Stephen Klasko, are still using the same, age-old methods to train doctors and have not evolved for the digital age.

"We recognize that technology will transform health care, but what member of any medical school faculty understands things like coding or social media at the level of their students?" he said.

Klasko sees potential for YouTube in medical training. Moreover, he notes, surgeons are increasingly being asked to use sophisticated hardware that requires a lot of additional training. One particularly popular type of content on YouTube is an instruction manual for Intuitive's da Vinci surgical robots, which can take months of practice to master. (This one, on how to suture a grape with a da Vinci, is particularly special.)

"These surgical robotics companies will go out of the way to credential people quickly," said Klasko. "But it's a tough skill to pick up."

In the interim, some doctors, like Jefferson Health's chief medical social media officer, Dr. Austin Chiang, who works for Klasko, recommend that their peers check whether a video is associated with a well-regarded hospital or medical society before they watch it or recommend it to others.

In the long run, he said, YouTube should promote this content over others. "One thing Google could do tomorrow is partner with these official societies," he said.

Follow @CNBCtech on Twitter for the latest tech industry news.

Link:
Doctors are turning to YouTube to learn how to do surgical procedures, but there's no quality control - CNBC

With the right-wing coup in Bolivia nearly complete, the junta is hunting down the last remaining dissidents – The Grayzone

On the day of my scheduled interview with a leftist journalist, I learned that he had been disappeared. Every outspoken opponent of the Bolivian junta is a target and subjected to charges of sedition.By Wyatt ReedIndigenous protesters carry coffins of their dead through La Paz (photo by Wyatt Reed)

La Paz, Bolivia As the military junta which seized power from the democratically-elected Bolivian President Evo Morales violently represses the working class, indigenous-led uprising against them, the country is rapidly falling under its control.

Soldiers in military fatigues prowl the streets, enforcing a series of choke points around the seat of power. Anyone perceived as standing against the status quo is now subject to being arrested on charges of sedition or terrorism, dissident journalists and Morales sympathizers have been forced into hiding, leaving the house only when necessary.

Its a fascist dictatorship, theres no hiding it, says Federico Koba, a left-wing journalist who asked that I not use his real name for fear of arrest. There are paramilitary agents going around the city taking pictures and pinpointing whos who. Who is a leader, who is recording the protests, who is recording the repression.

I met with Koba, an activist and journalist with the leftist news site, La Resistencia Bolivia, on the evening of November 24th. I had initially planned to meet with his co-worker, who asked that I refer to him by the pseudonym of Carlos Mujica because he too feared being jailed for his activism.

But on the day of our scheduled interview, Mujica never showed up. He was laying low, having had his house searched and ransacked by police the night before the coup.

Hours later, I received a brief message from him: Bro, I cant talk right now. Im in jail.

Mujicas friends went to every prison in the city looking for him, but he was nowhere to be found. The next day, he was released after an intense interrogation session in an unlisted facility. He immediately went into hiding, disconnecting himself completely from social media, which his peers now believe has been compromised by the coup government.

The atmosphere was grim when I met with Koba and some of his colleagues. We know for sure were on a list weve seen it, and what they did to Carlos confirms it, one member of La Resistencia told me.

After the interview with Koba, he waved off my suggestion that we get a beer.

Maybe someday, after all this is over, we can do that, he said. So we drove around under the cover of darkness instead, doubling back and making frequent turns to make sure we werent being followed.

That truck could belong to the cops, or the paramilitaries, he remarked, as we circled a roundabout multiple times to allow it to pass.

Since the country was taken over by far-right landowning elites, virtually every leftist Bolivian with a public profile has begun to feel the heat. Even relative newcomers to politics bear the scars of repression.

Minutes after meeting another Bolivian colleague whod first picked up a camera just weeks before, as the coup kicked off, he hiked up his pant leg to show me the wound hed sustained the day before. He had been shot with a rubber bullet while documenting the militarys offensive against the residents of El Alto.

Days after the coup sent Morales into exile, residents of the mostly indigenous, working class city of El Alto encircled the gas plant called Senkata, cutting off the nearby Bolivian capital of La Paz from its main source of cooking gas. In response, the same military and police forces that had conspired with fascist paramilitaries to force Morales from office unleashed a brutal wave of violence on the largely unarmed protesters.

I arrived just after the worst of the massacre. The terrorists as the Bolivian military junta and press have dubbed the self-organized patrols of mainly unarmed indigenous youth and mothers were decidedly less violent than one might expect. Instead of the guns and dynamite which coup-supporting Bolivians insist they wield, I saw only cell phones and polleras, the traditional dresses worn by many of Bolivias indigenous women.

But that did little to prevent them from being mowed down over the course of several hours. While the official death toll from the Senkata massacre now stands at nine, a seemingly endless series of victims family members told the OAS Inter-American Commission on Human Rights (CIDH) that the real number was most certainly higher: as many as twenty-five deaths.

Their harrowing testimonies painted a picture of an unhinged soldiers firing at random out of helicopters and from sniper perches. Mothers sobbed as they held up photos of their children. Many had been gunned down as they went to or from work; still more had simply disappeared. Nearly a week later, their families are beginning to assume that they were killed by soldiers who subsequently hid the bodies in order to lower the official number of casualties.

But the military junta now in control begged to differ. Interior Minister Arturo Murillo has publicly insisted that not a single shot was fired.

It was an account echoed by the head doctor of the Corazon de Jesus Trauma Center. He allowed me inside the medical clinic only after a crew of five nurses had scrubbed the puddles of blood from the floors. The doctor then insisted that only two of the victims could be confirmed as gunshot victims, and that their wounds were consistent with a .22 caliber weapon in his words, non-military weapons.

How someone with no training as a forensic pathologist could come to such a conclusion is confounding, but what is well known in Bolivia today is that any medical professional who contradicts the official narrative risks criminalization.

After a video of a crying medical professional in Senkata denouncing the horrific violence went viral, he was arrested just days later after the Bolivian regime accused him of being a fake doctor.

The wrath of the Aez junta government extends across the Bolivian left. Virtually anyone who represents a perceived challenge to the status quo is liable to be hit with manufactured charges of sedition or terrorism.

As Koba explained during our clandestine nighttime drive, they are trying to repress not only protesters that march, but anyone that says different from what the government says is happening. So they are repressing any media outlet that tries to show the repression and the assassinations, the killings, and show the evidence, and show the protests, and show the marches. Everything thats against the coup is being harassed and is being attacked.

He continued: A lot of small and medium-sized media outlets have been shut down or have been forced to not show whats going on, and others have been paid to show what they tell them to. So its a very serious situation in the freedom of speech department not only the human rights department because as I think the world has seen, these guys havent held back in using all the force at their disposal.

Prestige and prominence is no protection under the rule of the junta. Even five-time Emmy-winning journalist Carlos Montero and Juan Manuel Karg were forced from the country after one fanatically right-wing senator labelled them insufferable communists who were sticking their dirty noses in Bolivia.

Police hit an Al-Jazeera reporter transmitting from the Plaza Murillo in La Paz in the face with tear gas as she attempted to deliver her report.

And Telesur, one of the last remaining news channels to give a voice to opponents of the coup government, had numerous correspondents kicked out of the country on accusations of sedition before the station was officially removed from the airwaves on November 21st.

But the repression of international media has paled in comparison to the right-wing repression of local Bolivian media. Within days of the coup, Jos Aramayo, director of Radio CSUTCB an ally of Morales was chained to a tree as paramilitary members frogmarched his staff out of their office.

As Koba explained, Bolivian media outlets now face a choice: either you take a bribe, or your life will be made extremely difficult. In this atmosphere, opposing viewpoints are virtually non-existent on Bolivian TV, which now runs PSAs warning that Evo Morales is trying to starve the audience.

We are almost alone in showing whats going on, Koba said of the threatened band of leftist reporters still active in Bolivia. The traditional media is just showing what they cant hide. But they of course deny the evidence. They say that these were inside jobs that cocaleros and El Alto people are killing themselves.

In the Alice in Wonderland post-truth reality enforced by the junta, he exclaimed, The progressives are the fascists. They say that we are the fascists! They say that we are the violent ones, that we are the terrorists. They say that we are the ones who performed the coup from a long time before with this alleged fraud, this supposed fraud.

While a few scattered progressives in the US Congress have registered their condemnation of the coup, the damage has been done, and the plot has been fulfilled.

The far-right demagogues who forced Morales have consolidated control, and as Koba says, they tried to turn everything upside down so the election fraud was a coup, and the coup was a return to democracy; the paramilitary forces are pacifying forces; the fascists are the democrats.

Everything, he says, is upside down.

Bolivia has become a huge laboratory for post-truth and 21st century coups that use everything that they have gathered up from their experiences in Nicaraguan and Venezuela, onto Honduras. Brazil and Argentina, Koba maintained.

In 2008, they tried to throw a coup here, and they were unsuccessful, but they learned from their mistakes. This has been a laboratory to use all of their guns the post-truth, the paramilitary, the civil movements being financed by NGOs and by foreign fascist organizations.

Now, Koba warns, anyone who says that this isnt a transitional government is accused of creating sedition. And everything is sedition. Posting on social media is sedition, talking about the violent repression is sedition, saying what you think is sedition.

According to Koba, The only thing that they havent been able to do, is to convince the international community that this is a democratic transition. Of course, thats the only thing that we have in our favor, that the international community has seen the repression, has seen all the human rights violations.

As Bolivia returns to the dark days of de facto rule by a ruthless, US-backed military junta, Kobas voice is among only a few who still dare to speak out in protest.

After a long and sobering discussion, we returned to downtown La Paz. I shook his hand and wished him well, unsure when or if I would see him again.

Wyatt Reed is a Virginia-based activist and journalist who covers climate and racial justice movements and foreign policy issues. Follow him on Twitter at @wyattreed13.

More:
With the right-wing coup in Bolivia nearly complete, the junta is hunting down the last remaining dissidents - The Grayzone